BOSTON SCIENTIFIC CORPORATION Receivable with Imputed Interest, Effective Yield (Interest Rate)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Receivable with Imputed Interest, Effective Yield (Interest Rate) of 1.50% for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-07-31.
Discontinued › Notes › and Others
us-gaap:ReceivableWithImputedInterestEffectiveYieldInterestRate · last filed 2018-07-31
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for the quarter ending 2018-03-31 was 2.10%, a 90.91% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for the quarter ending 2017-03-31 was 1.10%, a 35.29% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for the quarter ending 2016-09-30 was 1.70%, a 32.00% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for the quarter ending 2016-06-30 was 1.80%, a 43.75% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for fiscal 2015 was 2.40%, a 25.00% decline from fiscal 2014.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for fiscal 2014 was 3.20%, a 3.90% decline from fiscal 2013.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for fiscal 2013 was 3.33%, a 108.13% increase from fiscal 2012.
- BOSTON SCIENTIFIC CORPORATION receivable with imputed interest, effective yield (interest rate) for fiscal 2012 was 1.60%.
| Period end | Receivable with Imputed Interest, Effective Yield (Interest Rate) 3 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 6 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 9 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 12 month | Receivable with Imputed Interest, Effective Yield (Interest Rate) 12 month as first filed |
|---|---|---|---|---|---|
| 2018-06-30 | 1.50% 10-Q · filed 2018-07-31 | ||||
| 2018-03-31 | 2.10% 10-Q · filed 2018-05-01 | ||||
| 2017-12-31 | 1.80% 10-Q · filed 2018-07-31 | ||||
| 2017-09-30 | 1.60% 10-Q · filed 2017-11-02 | ||||
| 2017-06-30 | 1.80% 10-Q · filed 2017-08-03 | ||||
| 2017-03-31 | 1.10% 10-Q · filed 2017-05-03 | ||||
| 2016-12-31 | 1.80% 10-Q · filed 2018-05-01 | ||||
| 2016-09-30 | 1.70% 10-Q · filed 2016-11-03 | ||||
| 2016-06-30 | 1.80% 10-Q · filed 2016-08-03 | ||||
| 2016-03-31 | 1.70% 10-Q · filed 2016-05-04 | ||||
| 2015-12-31 | 2.40% 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | 2.50% 10-Q · filed 2015-11-04 | ||||
| 2015-06-30 | 3.20% 10-Q · filed 2015-08-06 | ||||
| 2015-03-31 | 5.30% 10-Q · filed 2015-05-06 | ||||
| 2014-12-31 | 3.20% 10-K · filed 2016-02-24 | ||||
| 2014-09-30 | 2.90% 10-Q · filed 2014-11-05 | ||||
| 2014-06-30 | 3.10% 10-Q · filed 2014-08-06 | ||||
| 2014-03-31 | 3.60% 10-Q · filed 2014-05-08 | ||||
| 2013-12-31 | 3.33% 10-K · filed 2015-02-25 | 3.30% 10-K · filed 2014-02-26 | |||
| 2013-09-30 | 3.30% 10-Q · filed 2013-11-05 | ||||
| 2013-06-30 | 3.50% 10-Q · filed 2013-08-07 | ||||
| 2013-03-31 | 3.80% 10-Q · filed 2013-05-07 | ||||
| 2012-12-31 | 1.60% 10-K · filed 2014-02-26 | ||||
| 2012-09-30 | 2.50% 10-Q · filed 2012-11-06 | ||||
| 2012-06-30 | 2.40% 10-Q · filed 2012-08-07 | ||||
| 2012-03-31 | 3.50% 10-Q · filed 2012-05-03 | ||||
| 2011-12-31 | 3.30% 8-K · filed 2013-05-29 | ||||
| 2011-09-30 | 2.50% 10-Q · filed 2011-11-08 | ||||
| 2011-06-30 | 2.50% 10-Q · filed 2011-08-05 | ||||
| 2011-03-31 | 2.30% 10-Q · filed 2011-05-05 | ||||
| 2010-12-31 | 2.00% 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |